Role of Embolization in the Treatment of Renal Masses

 

 Buy Article Permissions and Reprints

Abstract

Renal arterial embolization (RAE) performed for the treatment of renal masses has been proven to be a safe and effective technique, with several decades of experience. RAE is well tolerated with few complications, particularly if the time interval from embolization to surgery is reduced to less than 48 hours. Review of the literature suggests that RAE is also extremely effective for palliation of symptoms in the setting of nonoperative advanced stage renal cell carcinoma. In addition, this technique plays a large role in the management of angiomyolipomas that are symptomatic or at risk of spontaneous rupture. To date, RAE has not been evaluated in a randomized controlled setting, which has contributed to its underutilization. All of these potential benefits warrant the need for prospective studies for further validation.

• References

• 1 Motzer RJ, Agarwal N, Beard C , et al; National Comprehensive Cancer Network. Kidney cancer. J Natl Compr Canc Netw 2011; 9 (9) 960-977
  PubMedGoogle Scholar
• 2 Russo P. The role of surgery in the management of early-stage renal cancer. Hematol Oncol Clin North Am 2011; 25 (4) 737-752
  CrossrefPubMedGoogle Scholar
• 3 Arenson AM, Graham RT, Shaw P, Srigley J, Herschorn S. Angiomyolipoma of the kidney extending into the inferior vena cava: sonographic and CT findings. AJR Am J Roentgenol 1988; 151 (6) 1159-1161
  CrossrefPubMedGoogle Scholar
• 4 Katabathina VS, Vikram R, Nagar AM, Tamboli P, Menias CO, Prasad SR. Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics 2010; 30 (6) 1525-1540
  CrossrefPubMedGoogle Scholar
• 5 Kothary N, Soulen MC, Clark TW , et al. Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol 2005; 16 (1) 45-50
  CrossrefPubMedGoogle Scholar
• 6 Ramon J, Rimon U, Garniek A , et al. Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol 2009; 55 (5) 1155-1161
  CrossrefPubMedGoogle Scholar
• 7 Sauk S, Zuckerman DA. Renal artery embolization. Semin Intervent Radiol 2011; 28 (4) 396-406
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Almgård LE, Slezak P. Treatment of renal adenocarcinoma by embolization: a follow-up of 38 cases. Eur Urol 1977; 3 (5) 279-281
  CrossrefPubMedGoogle Scholar
• 9 Kalman D, Varenhorst E. The role of arterial embolization in renal cell carcinoma. Scand J Urol Nephrol 1999; 33 (3) 162-170
  CrossrefPubMedGoogle Scholar
• 10 Madoff D, Verma R, Ahrar K. Embolotherapy for organ ablation. In: Golzarian J, Sun S, Sharafuddin M, , eds. Vascular Embolotherapy. Germany: Springer-Verlag; 2006: 201-20
  CrossrefGoogle Scholar
• 11 Sauk S, Zuckerman DA. Renal artery embolization. Semin Intervent Radiol 2011; 28 (4) 396-406
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Ginat DT, Saad WE, Turba UC. Transcatheter renal artery embolization: clinical applications and techniques. Tech Vasc Interv Radiol 2009; 12 (4) 224-239
  CrossrefPubMedGoogle Scholar
• 13 Loffroy R, Rao P, Kwak BK , et al. Transcatheter arterial embolization in patients with kidney diseases: an overview of the technical aspects and clinical indications. Korean J Radiol 2010; 11 (3) 257-268
  CrossrefPubMedGoogle Scholar
• 14 Loffroy R, Rao P, Ota S, Geschwind JF. Renal artery embolisation prior to radical nephrectomy for renal cell carcinoma: when, how and why?. Br J Radiol 2010; 83 (991) 630 , author reply 631–632
  CrossrefPubMedGoogle Scholar
• 15 Schwartz MJ, Smith EB, Trost DW, Vaughan Jr ED. Renal artery embolization: clinical indications and experience from over 100 cases. BJU Int 2007; 99 (4) 881-886
  CrossrefPubMedGoogle Scholar
• 16 May M, Brookman-Amissah S, Pflanz S, Roigas J, Hoschke B, Kendel F. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma. Br J Radiol 2009; 82 (981) 724-731
  CrossrefPubMedGoogle Scholar
• 17 Zielinski H, Szmigielski S, Petrovich Z. Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma. Am J Clin Oncol 2000; 23 (1) 6-12
  CrossrefPubMedGoogle Scholar
• 18 Subramanian VS, Stephenson AJ, Goldfarb DA, Fergany AF, Novick AC, Krishnamurthi V. Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology 2009; 74 (1) 154-159
  CrossrefPubMedGoogle Scholar
• 19 Maxwell NJ, Saleem Amer N, Rogers E, Kiely D, Sweeney P, Brady AP. Renal artery embolisation in the palliative treatment of renal carcinoma. Br J Radiol 2007; 80 (950) 96-102
  CrossrefPubMedGoogle Scholar
• 20 Mukund A, Gamanagatti S. Ethanol ablation of renal cell carcinoma for palliation of symptoms in advanced disease. J Palliat Med 2010; 13 (2) 117-120
  CrossrefPubMedGoogle Scholar
• 21 Munro NP, Woodhams S, Nawrocki JD, Fletcher MS, Thomas PJ. The role of transarterial embolization in the treatment of renal cell carcinoma. BJU Int 2003; 92 (3) 240-244
  CrossrefPubMedGoogle Scholar
• 22 Onishi T, Oishi Y, Suzuki Y, Asano K. Prognostic evaluation of transcatheter arterial embolization for unresectable renal cell carcinoma with distant metastasis. BJU Int 2001; 87 (4) 312-315
  CrossrefPubMedGoogle Scholar
• 23 Tigrani VS, Reese DM, Small EJ, Presti Jr JC, Carroll PR. Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis. Urology 2000; 55 (1) 36-40
  CrossrefPubMedGoogle Scholar
• 24 Halpenny D, Snow A, McNeill G, Torreggiani WC. The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol 2010; 65 (2) 99-108
  CrossrefPubMedGoogle Scholar
• 25 Oesterling JE, Fishman EK, Goldman SM, Marshall FF. The management of renal angiomyolipoma. J Urol 1986; 135 (6) 1121-1124
  PubMedGoogle Scholar
• 26 Soulen MC, Faykus Jr MH, Shlansky-Goldberg RD, Wein AJ, Cope C. Elective embolization for prevention of hemorrhage from renal angiomyolipomas. J Vasc Interv Radiol 1994; 5 (4) 587-591
  CrossrefPubMedGoogle Scholar
• 27 Lee SY, Hsu HH, Chen YC , et al. Evaluation of renal function of angiomyolipoma patients after selective transcatheter arterial embolization. Am J Med Sci 2009; 337 (2) 103-108
  CrossrefPubMedGoogle Scholar
• 28 Boorjian SA, Frank I, Inman B , et al. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology 2007; 70 (6) 1064-1068
  CrossrefPubMedGoogle Scholar
• 29 Fazeli-Matin S, Novick AC. Nephron-sparing surgery for renal angiomyolipoma. Urology 1998; 52 (4) 577-583
  CrossrefPubMedGoogle Scholar
• 30 Heidenreich A, Hegele A, Varga Z, von Knobloch R, Hofmann R. Nephron-sparing surgery for renal angiomyolipoma. Eur Urol 2002; 41 (3) 267-273
  CrossrefPubMedGoogle Scholar
• 31 Yip SK, Tan PH, Cheng WS, Li MK, Foo KT. Surgical management of angiomyolipoma: nephron-sparing surgery for symptomatic tumour. Scand J Urol Nephrol 2000; 34 (1) 32-35
  CrossrefPubMedGoogle Scholar
• 32 Katsanos K, Sabharwal T, Ahmad F, Dourado R, Adam A. Onyx embolization of sporadic angiomyolipoma. Cardiovasc Intervent Radiol 2009; 32 (6) 1291-1295
  CrossrefPubMedGoogle Scholar
• 33 Lenton J, Kessel D, Watkinson AF. Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin Radiol 2008; 63 (8) 864-870
  CrossrefPubMedGoogle Scholar
• 34 Villalta JD, Sorensen MD, Durack JC, Kerlan RK, Stoller ML. Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents. J Urol 2011; 186 (3) 921-927
  CrossrefPubMedGoogle Scholar
• 35 Chan CK, Yu S, Yip S, Lee P. The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma. Urology 2011; 77 (3) 642-648
  CrossrefPubMedGoogle Scholar
• 36 Ewalt DH, Diamond N, Rees C , et al. Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J Urol 2005; 174 (5) 1764-1766
  CrossrefPubMedGoogle Scholar
• 37 Williams JM, Racadio JM, Johnson ND, Donnelly LF, Bissler JJ. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am J Kidney Dis 2006; 47 (1) 95-102
  PubMedGoogle Scholar
• 38 Wallace S, Chuang VP, Swanson D , et al. Embolization of renal carcinoma. Radiology 1981; 138 (3) 563-570
  PubMedGoogle Scholar
• 39 Lin PH, Terramani TT, Bush RL, Keane TE, Moore RG, Lumsden AB. Concomitant intraoperative renal artery embolization and resection of complex renal carcinoma. J Vasc Surg 2003; 38 (3) 446-450
  CrossrefPubMedGoogle Scholar
• 40 Carvajal R, Orgaz A, Leal JI , et al. Renal embolization and nephrectomy in a single surgical act in high-risk renal tumor pathology. Ann Vasc Surg 2011; 25 (2) 222-228
  CrossrefPubMedGoogle Scholar
• 41 Peng ZW, Zhang YJ, Chen MS , et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013; 31 (4) 426-432
  CrossrefPubMedGoogle Scholar
• 42 Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012; 262 (2) 689-700
  CrossrefPubMedGoogle Scholar
• 43 Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2013; 139 (4) 653-659
  CrossrefPubMedGoogle Scholar
• 44 Peng ZW, Chen MS. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma. Oncology 2013; 84 (Suppl. 01) 40-43
  CrossrefPubMedGoogle Scholar
• 45 Rossi S, Garbagnati F, Lencioni R , et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217 (1) 119-126
  CrossrefPubMedGoogle Scholar
• 46 Li Y, Guo Z, Liu CF , et al. Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma. Cryobiology 2012; 65 (1) 56-59
  CrossrefPubMedGoogle Scholar
• 47 Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol 2012; (23) (Suppl. 08) 6-9
  PubMedGoogle Scholar
• 48 Yamakado K, Nakatsuka A, Kobayashi S , et al. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc Intervent Radiol 2006; 29 (3) 389-394
  CrossrefPubMedGoogle Scholar
• 49 Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K, Sugimura Y. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Int J Urol 2007; 14 (7) 585-590 , discussion 590
  CrossrefPubMedGoogle Scholar
• 50 Mondshine RT, Owens S, Mondschein JI, Cizman B, Stavropoulos SW, Clark TW. Combination embolization and radiofrequency ablation therapy for renal cell carcinoma in the setting of coexisting arterial disease. J Vasc Interv Radiol 2008; 19 (4) 616-620
  CrossrefPubMedGoogle Scholar
• 51 Woodrum DA, Atwell TD, Farrell MA, Andrews JC, Charboneau JW, Callstrom MR. Role of intraarterial embolization before cryoablation of large renal tumors: a pilot study. J Vasc Interv Radiol 2010; 21 (6) 930-936
  CrossrefPubMedGoogle Scholar
• 52 Nakasone Y, Kawanaka K, Ikeda O, Tamura Y, Yamashita Y. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study. Acta Radiol 2012; 53 (4) 410-414
  CrossrefPubMedGoogle Scholar
• 53 Frasson F, Fugazzola C, Bianchi G , et al. Selective arterial embolization in renal tumors. Radiol Clin (Basel) 1978; 47 (4) 239-251
  PubMedGoogle Scholar
• 54 Schulman CC, Struyven J, Giannakopoulos X, Mathieu J. Preoperative embolization of renal tumors—comparison of different methods. Eur Urol 1980; 6 (3) 154-157
  PubMedGoogle Scholar
• 55 Frasson F, Roversi RA, Simonetti G, Ziviello M. Embolization of renal tumors. A survey of the Italian experience : 282 patients. Ann Radiol (Paris) 1981; 24 (5) 396-399
  PubMedGoogle Scholar
• 56 Giuliani L, Carmignani G, Belgrano E, Puppo P, Quattrini S. Usefulness of preoperative transcatheter embolization in kidney tumors. Urology 1981; 17 (5) 431-434
  CrossrefPubMedGoogle Scholar
• 57 Kato T, Nemoto R, Mori H, Takahashi M, Harada M. Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs. Cancer 1981; 48 (3) 674-680
  CrossrefPubMedGoogle Scholar
• 58 Mobilio G, Cavalli A, Bianchi G. Preoperative arterial occlusion in renal tumors: 3 years experience. Int Urol Nephrol 1981; 13 (1) 25-33
  CrossrefPubMedGoogle Scholar
• 59 LeGuillou M, Merland JJ. The indications of embolisation in renal tumor: what remains to be said?. Prog Clin Biol Res 1982; 100: 603-607
  PubMedGoogle Scholar
• 60 Teasdale C, Kirk D, Jeans WD, Penry JB, Tribe CT, Slade N. Arterial embolisation in renal carcinoma: a useful procedure?. Br J Urol 1982; 54 (6) 616-619
  CrossrefPubMedGoogle Scholar
• 61 Bono AV, Caresano A. The role of embolization in the treatment of kidney carcinoma. Eur Urol 1983; 9 (6) 334-337
  PubMedGoogle Scholar
• 62 Nakano H, Nihira H, Toge T. Treatment of renal cancer patients by transcatheter embolization and its effects on lymphocyte proliferative responses. J Urol 1983; 130 (1) 24-27
  CrossrefPubMedGoogle Scholar
• 63 Ekelund L, Ek A, Forsberg L , et al. Occlusion of renal arterial tumor supply with absolute ethanol. Experience with 20 cases. Acta Radiol Diagn (Stockh) 1984; 25 (3) 195-201
  PubMedGoogle Scholar
• 64 Kaisary AV, Williams G, Riddle PR. The role of preoperative embolization in renal cell carcinoma. J Urol 1984; 131 (4) 641-646
  PubMedGoogle Scholar
• 65 Kurth KH, Cinqualbre J, Oliver RT, Schulman CC. Embolization and subsequent nephrectomy in metastatic renal cell carcinoma. Prog Clin Biol Res 1984; 153: 423-436
  PubMedGoogle Scholar
• 66 McIvor J, Kaisary AV, Williams G, Grant RW. Tumour infarction after pre-operative embolisation of renal carcinoma. Clin Radiol 1984; 35 (1) 59-64
  CrossrefPubMedGoogle Scholar
• 67 Mebust WK, Weigel JW, Lee KR, Cox GG, Jewell WR, Krishnan EC. Renal cell carcinoma—angioinfarction. J Urol 1984; 131 (2) 231-235
  PubMedGoogle Scholar
• 68 Christensen K, Dyreborg U, Andersen JF, Nissen HM. The value of transvascular embolization in the treatment of renal carcinoma. J Urol 1985; 133 (2) 191-193
  PubMedGoogle Scholar
• 69 Gottesman JE, Crawford ED, Grossman HB, Scardino P, McCracken JD. Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study. Urology 1985; 25 (3) 248-250
  CrossrefPubMedGoogle Scholar
• 70 Klimberg I, Hunter P, Hawkins IF, Drylie DM, Wajsman Z. Preoperative angioinfarction of localized renal cell carcinoma using absolute ethanol. J Urol 1985; 133 (1) 21-24
  PubMedGoogle Scholar
• 71 Lammer J, Justich E, Schreyer H, Pettek R. Complications of renal tumor embolization. Cardiovasc Intervent Radiol 1985; 8 (1) 31-35
  CrossrefPubMedGoogle Scholar
• 72 Leinonen A. Embolization of renal carcinoma. Comparison between the early results of Gelfoam and absolute ethanol embolization. Ann Clin Res 1985; 17 (6) 299-305
  PubMedGoogle Scholar
• 73 Weigel JW, Mebust WK, Foret JD , et al. Treatment of renal cell carcinoma with renal infarction, delayed nephrectomy, medroxyprogesterone, and xenogeneic immune RNA. Urology 1985; 25 (2) 103-105
  PubMedGoogle Scholar
• 74 Chudácek Z, Zavázal V. Palliative embolization of renal tumors. I. Immunologic reaction to the embolization. Radiol Diagn (Berl) 1986; 27 (2) 211-213
  PubMedGoogle Scholar
• 75 Karwowski A, Wojtowicz J. Long-term results of embolization in renal tumors. Radiol Diagn (Berl) 1987; 28 (4) 533-535
  PubMedGoogle Scholar
• 76 Kurth KH, Debruyne FM, Hall RR , et al. Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma. Eur Urol 1987; 13 (4) 251-255
  PubMedGoogle Scholar
• 77 Nurmi M, Satokari K, Puntala P. Renal artery embolization in the palliative treatment of renal adenocarcinoma. Scand J Urol Nephrol 1987; 21 (2) 93-96
  CrossrefPubMedGoogle Scholar
• 78 Stoesslein F, Schwenke A, Muenster W. Percutaneous transluminal embolization for improved prognosis of renal cell carcinoma—dependence on tumor stages. Cardiovasc Intervent Radiol 1988; 11 (2) 91-96
  CrossrefPubMedGoogle Scholar
• 79 Swanson DA, Wallace S. Surgery of metastatic renal cell carcinoma and use of renal infarction. Semin Surg Oncol 1988; 4 (2) 124-128
  PubMedGoogle Scholar
• 80 Kato T, Sato K, Abe R, Moriyama M. The role of embolization/chemoembolization in the treatment of renal cell carcinoma. Prog Clin Biol Res 1989; 303: 697-705
  PubMedGoogle Scholar
• 81 Lanigan D, Jurriaans E, Hammonds JC, Wells IP, Choa RG. The current status of embolization in renal cell carcinoma—a survey of local and national practice. Clin Radiol 1992; 46 (3) 176-178
  CrossrefPubMedGoogle Scholar
• 82 Bakal CW, Cynamon J, Lakritz PS, Sprayregen S. Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Interv Radiol 1993; 4 (6) 727-731
  CrossrefPubMedGoogle Scholar
• 83 Park JH, Kim SH, Han JK, Chung JW, Han MC. Transcatheter arterial embolization of unresectable renal cell carcinoma with a mixture of ethanol and iodized oil. Cardiovasc Intervent Radiol 1994; 17 (6) 323-327
  PubMedGoogle Scholar
• 84 Chick CM, Tan BS, Cheng C , et al. Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int 2010; 105 (3) 390-394
  CrossrefPubMedGoogle Scholar
• 85 Lee SY, Hsu HH, Chen YC , et al. Embolization of renal angiomyolipomas: short-term and long-term outcomes, complications, and tumor shrinkage. Cardiovasc Intervent Radiol 2009; 32 (6) 1171-1178
  CrossrefPubMedGoogle Scholar
• 86 Takebayashi S, Horikawa A, Arai M, Iso S, Noguchi K. Transarterial ethanol ablation for sporadic and non-hemorrhaging angiomyolipoma in the kidney. Eur J Radiol 2009; 72 (1) 139-145
  CrossrefPubMedGoogle Scholar
• 87 Bishay VL, Crino PB, Wein AJ , et al. Embolization of giant renal angiomyolipomas: technique and results. J Vasc Interv Radiol 2010; 21 (1) 67-72
  CrossrefPubMedGoogle Scholar
• 88 Chatziioannou A, Gargas D, Malagari K , et al. Transcatheter arterial embolization as therapy of renal angiomyolipomas: the evolution in 15 years of experience. Eur J Radiol 2012; 81 (9) 2308-2312
  CrossrefPubMedGoogle Scholar
• 89 Patatas K, Robinson GJ, Ettles DF, Lakshminarayan R. Patterns of renal angiomyolipoma regression post embolisation on medium- to long-term follow-up. Br J Radiol 2013; 86 (1024) 20120633
  CrossrefPubMedGoogle Scholar